SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant Response

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant Response	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Not yet recruiting	Phase 2	2025-08-26		NCT07129187

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chuan Wang	1

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials